What is Multiple Myeloma ?

Myeloma is a plasma cell neoplasm because it arises from plasma cells, specialized white blood cells that develop in bone marrow. Plasma cells are vital to immunity because they produce antibodies that help the body combat infectious diseases. Through their abnormal growth, plasma cells in multiple myeloma disrupt immune system processes and damage multiple organs.

Multiple myeloma spreads through the body by affecting bone marrow, which serves as its primary site of growth for solid tumors, and abnormal plasma cells cause excessive amounts of a specific type of atypical antibody, known as a monoclonal protein or paraprotein. The presence of these abnormal proteins in the body leads to organ damage, affecting kidney function and hindering normal blood cell production.

Multiple myeloma represents a complicated blood cancer because it impacts bone marrow and several other body systems, including bone, the immune system, the kidneys, and blood chemical balance. This illness may progress slowly in some, but in others, it may progress quickly. with medical advances, patients can now achieve better survival rates and quality of life through specific therapies, immunotherapy, stem cell transplants, and chemotherapy.

Moving forward, greater medical knowledge about multiple myeloma is essential for developing more effective detection techniques and treatment plans that lead to successful patient outcomes.

How do Plasma Cells and Bone Marrow Work ?

Understanding multiple myeloma requires knowledge of plasma cell function and bone marrow tissue.

The soft tissue within bones, where new blood cells are formed, is called bone marrow. The bone marrow produces three essential blood cell types, which include:

• Red blood cells, which deliver oxygen, circulate throughout the body.
• White blood cells, which help fight infections
• Platelets, which cause blood to clot and prevent bleeding

B lymphocytes produce plasma cells, which function as white blood cells, and one of their primary functions is to produce antibodies that recognize and kill bacteria and viruses.

Healthy individuals produce plasma cells in a controlled way to generate multiple antibody types, which safeguard their bodies against infections. Genetic alterations in multiple myeloma cause plasma cells to transform into malignant cancer cells. The abnormal cells multiply excessively and accumulate in the bone marrow.

The increasing number of malignant plasma cells leads to the replacement of healthy blood-forming cells, which results in complications such as anemia, infections, and bone damage.

What are the Different Types of Plasma Cell Neoplasms?

Multiple myeloma is one of several diseases categorized under the umbrella term “plasma cell neoplasms.” They all affect plasma cells to varying degrees, depending on the severity of the disease.

Monoclonal Gammopathy of Undetermined Significance (MGUS)

Multiple Myeloma is one of several diseases in the category of plasma cell neoplasms. Plasma cells are involved in different stages of abnormality, ranging from mild to advanced.

Smoldering Multiple Myeloma

Smoldering multiple myeloma is between MGUS and active multiple myeloma. They have a normal lifestyle but an increased plasma cell count, which explains the abnormal plasma cells.

Multiple Myeloma

The active disease state displays all its symptoms and manifestations. The condition leads to extensive plasma cell development from bone damage and results in organ complications.

Solitary Plasmacytoma

A plasmacytoma is a single tumor composed of damaged plasma cells. This condition can occur in either bone or soft tissue. Multiple myeloma may develop from a solitary plasmacytoma in specific situations.

Extramedullary Plasmacytoma

The tumor grows outside the bone marrow, typically in the throat, sinuses, and nasal passages.

The different types of medical conditions enable doctors to select which treatment methods and monitoring procedures they should use for their patients.

What are the Symptoms and Causes of Multiple Myeloma ?

Symptoms of Multiple Myeloma

The symptoms of multiple myeloma vary/differ depending on disease progression and the organs affected. Some patients develop mild symptoms at first, while others experience more serious health issues.

• Typical symptoms include ongoing back and rib pain.
• People experience extreme tiredness and physical weakness.
• People develop infections on multiple occasions.
• People develop unexplained weight loss.
• People experience nausea or lose their appetite.
• People experience an increased need to drink and urinate.
• People experience numbness or weakness in their legs.
• Patients develop simple bruises and have difficulty stopping their bleeding.

Bone damage is the most common symptom in patients with multiple myeloma. The disease weakens bones, increasing the risk of fractures. The spine, ribs, skull, pelvis, and long bones of the arms and legs are common sites of bone injury.

Hypercalcemia is another frequent complication, occurring when excessive calcium enters the bloodstream as a result of bone tissue breakdown. The symptoms of hypercalcemia include confusion, constipation, excessive thirst, and kidney problems.

Causes of Multiple Myeloma

The scientific community has not identified the exact causes of multiple myeloma. Researchers believe genetic mutations in plasma cells lead to uncontrolled cell growth. This, in turn, results in disease development.

People can develop these mutations through natural processes or environmental exposures. Abnormal plasma cells begin multiplying and produce large amounts of monoclonal protein, which harms organs.

What are the Risk Factors for Multiple Myeloma ?

The risk of developing multiple myeloma increases for several reasons.

• Age: Most cases of multiple myeloma occur in patients who are older than 60 years.
• Gender: Male individuals have a slightly higher risk of developing this disease compared to women.
• Family History: Having family members who developed multiple myeloma or similar conditions increases your risk. You are more likely to develop this disease.
• Exposure to Radiation or Chemicals: Your risk of developing blood cancers increases with exposure to chemicals, such as benzene. Radiation exposure also raises your risk.
• Obesity: Research indicates that being overweight may increase your chances of developing multiple myeloma.
• Preexisting Plasma Cell Disorders: People with MGUS or smoldering myeloma are likely to develop active multiple myeloma at some point.

How is Multiple Myeloma Diagnosed and Tested ?

The successful treatment of multiple myeloma requires early diagnosis. Doctors use multiple tests to confirm the presence of the disease and assess its level of severity.

Blood Tests

Blood tests serve a vital function by identifying abnormal proteins and assessing organ function.

The important blood tests consist of:

• Complete blood count (CBC)
• Serum protein electrophoresis
• Immunofixation tests
• Tests of calcium levels
• Tests of kidney function

These tests identify monoclonal proteins and assess consequences such as renal damage and anemia.

Testing Urine

Tests for Bence-Jones proteins, aberrant proteins produced by myeloma cells, are performed on urine samples.

Bone Marrow Biopsy

A bone marrow biopsy is an important diagnostic tool that involves removing a bone marrow sample, which medical staff will study under a microscope to count the abnormal plasma cell population.

Imaging Tests

Medical imaging tests allow doctors to see how bones are damaged and how far the illness has progressed.

The usual medical imaging procedures consist of:

• X-rays
• CT scans
• MRI scans
• PET scans

The tests reveal myeloma-related bone lesions, fractures, and tumors.

Cytogenetic & Molecular Testing

Advanced laboratory tests identify genetic defects that myeloma cells harbor. These tests enable physicians to assess the severity of the illness when selecting appropriate treatment methods.

How is Multiple Myeloma Staged?

The staging process determines how serious the disease is while it helps doctors develop appropriate treatment plans.

The Revised International Staging System (R-isS) uses multiple assessment criteria, which include:

• Beta-2 microglobulin levels
• Albumin levels
• Genetic abnormalities
• Lactate dehydrogenase levels

The classification system recognizes three stages of multiple myeloma, which progress from the initial disease phase to later advanced stages.

What are the Management and Treatment Options ?

The treatment methods used for multiple myeloma have advanced significantly over the last several years. Patients with the disease can receive various treatments, which will help them live longer while managing their chronic condition.

• Chemotherapy: Chemotherapy requires powerful drugs to destroy cancer cells, and such treatment functions as a component of combination therapy.
• Targeted Therapy: Targeted drugs attack specific proteins that myeloma cells rely on to survive. This class of drugs includes proteasome inhibitors and other targeted drugs.
• Immunotherapy: Immunotherapy strengthens the immune system, enabling it to recognize and destroy cancerous cells. New immunotherapy drugs have greatly helped many patients.
• Stem Cell Transplantation: Stem cell transplantation is a vital treatment option for patients who meet the criteria. The procedure begins with high-dose chemotherapy, which eliminates cancer cells. Afterward, doctors use healthy stem cell transplantation to bring back normal bone marrow function.
• Radiation Therapy: Radiation therapy functions to treat localized bone lesions while providing pain relief.

Supportive Treatments

The treatments help control disease complications in patients.

The treatment options consist of:

• Medications that strengthen bones
• Methods to handle pain
• Blood transfusions
• Antibiotic treatment for infections
• Medications that regulate calcium levels

What is the Outlook / Prognosis for multiple myeloma?

The prognosis of multiple myeloma depends on three main factors. These factors include the disease stage, existing genetic abnormalities, and treatment response.

Survival rates improved significantly due to advances in medical therapy. Patients can live for many years, or even decades, when they receive appropriate treatment and medical supervision.

Health professionals must conduct follow-up visits to monitor the disease's growth or progression and make necessary adjustments to the treatment plan based on what they observe.

Can Multiple Myeloma be Prevented ?

Scientists have not found any effective methods to prevent multiple myeloma. People can minimize the risk of developing cancer by improving their lifestyle, avoiding harmful substances, and regularly checking their health.

Patients with MGUS or smoldering myeloma need to experience continuous medical checks, which will help discover any disease progression at their earliest stage.

How can Patients Manage Life with Multiple Myeloma ?

Multiple myeloma creates difficulties for patients who can achieve a satisfactory quality of life through appropriate treatment and support.

To manage their disease, patients need to follow three essential practices: eating a healthy diet, engaging in moderate exercise, and taking steps to prevent illness.

People who experience chronic cancer diagnoses need psychological support services, together with counseling and patient support groups, which will help them face their emotional difficulties.

Why choose Tender Palm Super Speciality Hospital for Multiple Myeloma Treatment in Lucknow, India?

Tender Palm Super-Speciality Hospital offers advanced Multiple Myeloma treatment in Lucknow, India, at an affordable cost. We have a team of experienced medical oncologists and oncology specialists who provide accurate diagnosis and both non-surgical and surgical treatment options including chemotherapy, targeted therapy, immunotherapy, stem cell transplantation, and supportive care. Our Medical Oncology and Oncology team has decades of experience in successfully treating Multiple Myeloma in Lucknow, India.

To seek an Expert consultation for Multiple Myeloma Treatment in Lucknow, India:

Call us at +91-9076972161
Email at care@tenderpalm.com

Request a Call Back